Citaat:
Oorspronkelijk geplaatst door KaleDonder
Mijn redenatie:
De bijwerkingen van fina en dus waarschijnlijk ook dit product, worden
veroorzaakt door de (te) lage DHT waarden in het serum. .
|
Klopt dat te lage DHT waarden bijwerkingen kunnen geven.
Echter als je de DHT waarden bij Keratene Retard gebruik ziet dan dalen deze niet extreem, er is blijkbaar een limiet ingebouwd waaronder de DHT waarden niet gaan.
Meer info hierover in een post door dr. Arvind
extract van antwoord
Analyzing the results of the latest in vivo tests conducted on adult males medicated with the synthetic counterpart from the -steride group, we observed that this substance has a tremendous chemical potential to send DHT into a deep depression, under the biologically acceptable limits for adult males. In a side-by-side comparison, test subjects got very low DHT values, varying between 190 and 250 pg/ml. After 12 to 16 months of continuous administration, the test subjects reported onset of gynaecomastia combined with low athletic tonus, depressed libido tonic state, all the direct effect of severely depressed DHT levels, for sustained periods of time.
Based on the current clinical endocrinologic recommendations, maintaining male DHT levels between 400 and 800 pg/ml is an intrinsic condition for a healthy active male as well as for the exclusion of the onset of gynaecomastia.
Once the test subjects stopped the –steride-based medication, the DHT level bounced back to its “natural” level, after 4 to 5 days. Notably, DHT recovered from 200 pg/ml to 1995 pg/ml in a timeframe of 7 consecutive days, rising rapidly, in geometric progression. This translates into the conclusion that –steride-based substances have a low bio-accumulation time in healthy males, with a native substance half-life of up to 72 hours.
In contrast to the above substance, Kératene alphactive Retard reduced the DHT level to 390 – 430 pg/ml in just 6 to 7 days from administration, stabilizing its level at an average of 490 pg/ml, after 10 to 12 days of therapy, depending on the subject’s internal endocrine dynamics. The reduction curve produced by Kératene alphactive Retard follows a harmonic trend, mathematically elegant, without major shocks, whereas its counter-part acts in acute drops (super dip). The long-term stabilization mechanism employed by Kératene alphactive Retard depends on the personal endocrinologic profile and other internal factors and the exact values may vary discretely from individual to individual.
Also notable, unlike its synthetic counterpart from the –steride group, Kératene alphactive Retard does not penetrate the BB Barrier and it has no impact on Lutropin, DHEA or on sbhg. The analytical tests also showed that the compound does not suppress endocrine precursors, does not inhibit the enzyme production, does not inhibit the acceptor androgen T and it has no effect on the libido. Moreover, we observed FT and TT levels were stable through-out the trial, indicating not only that TT remains within safe limits but also the unmodified bio-availability of FT for immediate muscular metabolism.
Bron :
Er is een goede discussie over dit product te volgen :
http://www.hairsite.com/hair-loss/bo...casc-DESC.html